Oncologists Accepting Aetna in TexasPage 2
338 verified oncologists in Texas accept Aetna. Profiles cover focus areas including Radiation Oncology, Genitourinary Oncology, and Medical Oncology. Common hospital affiliations include University of Texas MD Anderson Cancer Center, University of Mississippi Medical Center, and Dan L. Duncan Comprehensive Cancer Center.


Beth Chasen, M.D.
Professor, Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Oncology


Sumit Subudhi, MD, PHD
Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Oncology


Tanya Moseley, M.D.
Professor of Breast Imaging and Breast Surgical Oncology; Vice Chair of Faculty Development, Division Chief of Breast Imaging, and Breast Imaging Fellowship Director, University of Mississippi Medical Center
Oncology


Milind Javle, MD
Professor, Department of Gastrointestinal Medical Oncology; Hubert L. and Olive Stringer Professor; Chair, NCI Task Force, Hepatobiliary Cancers
Oncology


Bora Lim, MD
Associate Professor, Department of Breast Medical Oncology, Division of Cancer Medicine, UT MD Anderson Cancer Center
Oncology


Andrew Brenner, M.D., PH.D.
Professor of Medicine, Cell Systems and Anatomy; Neuro-Oncology Program Leader; Co-Leader, Experimental and Developmental Therapeutics
Oncology


Bruno Odisio, M.D.
Professor, Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center; Co-Director of Research, Department of Interventional Radiology; Medical Director, Image-Guided Cancer Therapy Research Program
Oncology


Michael Overman, M.D.
Professor, Department of Gastrointestinal Medical Oncology; Associate Vice President of Research, Cancer Network, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Oncology


Sunyoung Lee, MD
Assistant Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Oncology


Renata Ferrarotto, MD
Professor and Director of Head and Neck Oncology Clinical Research, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine
Oncology


Fredrick Hagemeister, M.D.
Clinical Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Oncology


Vinod Ravi, MD
Professor, Department of Sarcoma Medical Oncology, Division of Cancer Medicine; Professor, Department of Genomic Medicine, Division of Cancer Medicine
Oncology


Funda Meric, M.D.
Chair, Department of Investigational Cancer Therapeutics; Medical Director, Institute for Personalized Cancer Therapy; Nellie B. Connally Chair in Breast Cancer; Professor, Department of Breast Surgical Oncology
Oncology


Michael Davies, M.D, PHD
Professor and Chairman of the Department of Melanoma Medical Oncology; Joint Professor, Department of Genomic Medicine; Co-Leader, Melanoma Moon Shot Program
Oncology


Zohra Nooruddin, M.D.
Associate Professor, Division of Hematology and Oncology; Medical Director, Bone Marrow Transplant Program; Interim Director, Stem Cell and Cellular Therapy Program
Oncology


Max Wintermark, MD
Chair, Department of Neuroradiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center; Professor, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center
Oncology


Anne Tsao, M.D.
Professor, Department of Thoracic/Head and Neck Medical Oncology; Thoracic Section Chief; Director, Mesothelioma Program; Director, Thoracic Chemo-Radiation Program; VP, Academic Affairs
Oncology


Chandrikha Chandrasekharan, M.D.
Clinical Associate Professor, Department of Cancer Medicine, Division of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Oncology


Cassian Yee, MD
Professor, Department of Melanoma Medical Oncology; Professor, Department of Immunology; Director, Department of Program for T Cell-Based Therapies (ProTCT), Division of Cancer Medicine
Oncology


Michael Kim, MD
Associate Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center
Oncology
Browse oncologists accepting Aetna by city
Drill into a specific Texas city.